Original Article
RELATIONSHIP BETWEEN G-CSF AND HYPERLEUKOCYTOSIS IN PATIENTS WITH APL AFTER TREATMENT WITH ALL-TRANS RETINOIC ACID
Abstract
Objective: To detect the G-CSF effect and its mechanism in hyperleucoeytosis of patients with APL after treatment with all-trans retinoic acid (ATRA).
Methods: MTT method was used to measure the proliferation of HL-60 cells or primary APL cells. cDNA-mRNA dot blot hybridization was used to detect the c-mye gene expression level of HL-60 cells after ATRA treatment. Cycle shift of HL-60 cells was measured by flow eytometric Analysis.
Results: ATRA could inhibit obviously in vitro the proliferation of HL-60 cells of primary APL cells. The G0/G1 ratio of HL-60 at 24 hours or 96 hours post-treatment with ATRA was increased, proliferation of HL-60 cells at the same time was promoted obviously under the condition of rhG. CSF. C-mye gone expression was analyzed by dot blot hybridization; its expression levels of 8, 24 or 96 hours in culture with ATRA separately were higher, low, high or lower as compared with each other.
Conclusion: GCSF plays an important role in hyperleucoeytosis of patients with APL after treatment with ATRA.
Methods: MTT method was used to measure the proliferation of HL-60 cells or primary APL cells. cDNA-mRNA dot blot hybridization was used to detect the c-mye gene expression level of HL-60 cells after ATRA treatment. Cycle shift of HL-60 cells was measured by flow eytometric Analysis.
Results: ATRA could inhibit obviously in vitro the proliferation of HL-60 cells of primary APL cells. The G0/G1 ratio of HL-60 at 24 hours or 96 hours post-treatment with ATRA was increased, proliferation of HL-60 cells at the same time was promoted obviously under the condition of rhG. CSF. C-mye gone expression was analyzed by dot blot hybridization; its expression levels of 8, 24 or 96 hours in culture with ATRA separately were higher, low, high or lower as compared with each other.
Conclusion: GCSF plays an important role in hyperleucoeytosis of patients with APL after treatment with ATRA.
